{"nct_id":"NCT01595009","title":"An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2011-04-27","start_date_type":null,"primary_completion_date":"2016-08-09","primary_completion_date_type":"ACTUAL","completion_date":"2016-08-09","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}